Topic: Acute Myeloid Leukemia.
Destination: Aid through which Pfizer will finance programs for the training of health professionals on advances in the treatment of Acute Myeloid Leukemia (AML) in patients not suitable for intensive chemotherapy, with the aim of helping these professionals in making decisions for evidence-based treatment.
Budget: 15 months.
Duration: $150,000.
Omple el següent formulari per rebre més informació:
Investiguem. Cuidem la teva salut.
Les aportacions solidàries ens ajuden a posar en marxa projectes de recerca que es tradueixen en avenços i millores en el diagnòstic, prevenció i tractament de malalties. Ajuda’ns a fer avançar la ciència i la salut fent una donació que es destinarà de manera íntegra a la línia de recerca que triïs!
Col·laboraGaleta | Durada | Descripció |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |